Publication: Inflammation mediated angiogenesis in chronic lymphocytic leukemia
| dc.contributor.author | Mitrović-Ajtić, Olivera (56586150800) | |
| dc.contributor.author | Živković, Emilija (57224736906) | |
| dc.contributor.author | Subotički, Tijana (55933499100) | |
| dc.contributor.author | Diklić, Miloš (35748587200) | |
| dc.contributor.author | Đikić, Dragoslava (42061363200) | |
| dc.contributor.author | Vukotić, Milica (59266277000) | |
| dc.contributor.author | Dragojević, Teodora (57224742546) | |
| dc.contributor.author | Vuković, Vojin (56180315400) | |
| dc.contributor.author | Antić, Darko (23979576100) | |
| dc.contributor.author | Čokić, Vladan P. (6507196877) | |
| dc.date.accessioned | 2025-06-12T11:41:36Z | |
| dc.date.available | 2025-06-12T11:41:36Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Chronic inflammation has been identified in leukemias as an essential regulator of angiogenesis. B-chronic lymphocytic leukemia (CLL) cells secrete high levels of vascular endothelial growth factor (VEGF) and hypoxia inducible factor 1 alpha (HIF1α). The aim was to assess the role of inflammation in activation of angiogenic factors: endothelial nitric oxide synthase (eNOS), HIF1α and VEGF via proliferation related signaling pathways and VEGF autocrine control. We isolated mononuclear cells (MNC) and CD19+ cells from peripheral blood of 60 patients with CLL. MNC were treated with pro-inflammatory interleukin-6 (IL-6) and VEGF, in combination with inhibitors of JAK1/2 (Ruxolitinib), mTOR (Rapamycin), NF-κB (JSH23), SMAD (LDN-193189) and PI3K/AKT (Ly294002) signaling pathways, to evaluate eNOS, VEGF and HIF1α expression by immunoblotting, immunocytochemistry and RT-qPCR. Also, we investigated IL-6 dependent neovascularization in human microvascular endothelial cells (HMEC-1) in co-culture with MNC of CLL. The angiogenic factors eNOS, VEGF and HIF1α had significantly higher frequencies in MNC of CLL in comparison to healthy controls (p < 0.001) and CD19+ cells of CLL. IL-6 increased the quantity of HIF1α (p < 0.05) and VEGF positive cells in the presence of JSH23 (p < 0.01). VEGF increased HIF1α (p < 0.05), and decreased eNOS gene expression (p < 0.01) in MNC of CLL. VEGF significantly (p < 0.001) increased the number of HIF1α positive MNC of CLL, prevented by inhibitors of JAK1/2, PI3K and mTOR signaling pathways. VEGF stimulation of SMAD (p < 0.05) and STAT5 (p < 0.01) signaling has been prevented by inhibitors of JAK1/2, mTOR, PI3K and SMAD signaling, individually (p < 0.01) or mutually (p < 0.001). Also, we showed that MNC of CLL and IL-6 individually stimulate neovascularization in co-culture with HMEC-1, without a cumulative effect. We demonstrated elevated angiogenic factors in CLL, while VEGF and IL-6 independently stimulated HIF1α. VEGF stimulation of HIF1α was mostly mTOR dependent, while IL-6 stimulation was NF-κB dependent. © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. | |
| dc.identifier.uri | https://doi.org/10.1007/s00277-024-05781-1 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192375194&doi=10.1007%2fs00277-024-05781-1&partnerID=40&md5=ff92c1c69473d2eb02b47c4d942411b0 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/967 | |
| dc.subject | Angiogenesis | |
| dc.subject | Chronic lymphocytic leukemia | |
| dc.subject | Inflammation | |
| dc.subject | Interleukin-6 | |
| dc.subject | Neovascularization | |
| dc.title | Inflammation mediated angiogenesis in chronic lymphocytic leukemia | |
| dspace.entity.type | Publication |
